ARS Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
SPRY
CUSIP
82835W108
Type
Equity
Class
COM
Num filings
7
Total reported value, excl. options
$1.06 M
Manager Report Date Value ($000) Shares Option Type